 reuters    the u s  senate on thursday passed a bill allowing the food and drug administration to continue collecting fees from drug companies to review new product applications  the fda reauthorization act renews an existing law that expires on sept   and which provides the majority of fda funds used to review pharmaceuticals and determine whether they are safe and effective  the senate passed the bill by a vote of    it was passed last month in the house of representatives  separately  the senate passed a so called right to try bill designed to allow terminally ill patients access to unapproved medications and to provide immunity for physicians willing to administer the treatments  the house has not yet passed that bill  